22,625 Shares in Rockwell Medical, Inc. (NASDAQ:RMTI) Purchased by Barclays PLC

Barclays PLC acquired a new position in Rockwell Medical, Inc. (NASDAQ:RMTI) during the third quarter, HoldingsChannel.com reports. The institutional investor acquired 22,625 shares of the company’s stock, valued at approximately $90,000.

A number of other large investors have also modified their holdings of RMTI. Armistice Capital LLC grew its position in Rockwell Medical by 22.5% in the 2nd quarter. Armistice Capital LLC now owns 3,221,640 shares of the company’s stock valued at $5,670,000 after buying an additional 592,000 shares in the last quarter. Jane Street Group LLC bought a new position in Rockwell Medical in the 3rd quarter valued at about $534,000. Walleye Capital LLC bought a new position in Rockwell Medical in the 3rd quarter valued at about $435,000. Renaissance Technologies LLC grew its position in Rockwell Medical by 877.1% in the 2nd quarter. Renaissance Technologies LLC now owns 102,700 shares of the company’s stock valued at $181,000 after buying an additional 92,189 shares in the last quarter. Finally, State Street Corp grew its position in Rockwell Medical by 21.5% in the 3rd quarter. State Street Corp now owns 95,004 shares of the company’s stock valued at $377,000 after buying an additional 16,800 shares in the last quarter. Institutional investors and hedge funds own 23.31% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on RMTI. HC Wainwright reiterated a “buy” rating and issued a $7.00 target price on shares of Rockwell Medical in a research report on Monday, December 23rd. Rodman & Renshaw began coverage on shares of Rockwell Medical in a research report on Thursday, November 14th. They issued a “buy” rating and a $5.00 target price for the company. StockNews.com lowered shares of Rockwell Medical from a “buy” rating to a “hold” rating in a research report on Friday, December 20th. Finally, RODMAN&RENSHAW upgraded shares of Rockwell Medical to a “strong-buy” rating in a research report on Thursday, November 14th.

Rockwell Medical Stock Performance

NASDAQ:RMTI opened at $2.13 on Thursday. Rockwell Medical, Inc. has a twelve month low of $1.16 and a twelve month high of $5.15. The company has a current ratio of 2.41, a quick ratio of 2.00 and a debt-to-equity ratio of 0.33. The company has a 50-day moving average of $2.55 and a 200-day moving average of $2.73. The firm has a market cap of $68.84 million, a price-to-earnings ratio of -42.60 and a beta of 1.38.

About Rockwell Medical

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.